Guo-Liang Yu

Guo-Liang Yu is the current CEO at Apollomics. Guo-Liang has over 25 years of experience in the biopharmaceutical industry. Prior to joining Apollomics, they were the Exec Chairman at Crown Bioscience, Inc. from January 2013 to June 2018. Before that, they were Sr VP of R&D at Mendel Biotechnology, Inc. from January 1998 to December 2002. Guo-Liang also worked at Human Genome Sciences as a Sr Scientist from January 1993 to December 1998.

Guo-Liang Yu received their Bachelor's degree in Biochemistry from Fudan University. Guo-Liang then went on to earn their Post-Doctorate in Genetics and Molecular Biology from Harvard Medical School - Massachusetts General Hospital. Finally, they received their Doctor of Philosophy - PhD in Molecular Biology from the University of California, Berkeley.

Some direct reports include Scott Houston - SVP Clinical Operations, Qian Shi - China General Manager Head of Science, and Sanjeev Redkar - President.